Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia

The aim of this study is to optimize the timing of erythropoietin gene modified mesenchymal stem cells (EPO‐MSCs) transplantation for bronchopulmonary dysplasia (BPD). Three weeks post‐operation, the results indicated that the damage of airway structure and apoptosis were significantly decreased, th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cell Mol Med
Autori principali: Zhang, Zhaohua, Sun, Chao, Wang, Jue, Jiang, Wen, Xin, Qian, Luan, Yun
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Short Communications
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201357/
https://ncbi.nlm.nih.gov/pubmed/30160360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13843
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi